课题基金 / 基金详情

Searches for the molecular pathogenesis of skeretal and neuronal system from serum calcium-decreasing factor, caldecrin, knock out mouse

Searches for the molecular pathogenesis of skeretal and neuronal system from serum calcium-decreasing factor, caldecrin, knock out mouse
从血清降钙因子、降钙蛋白、基因敲除小鼠中寻找骨骼和神经系统的分子发病机制
批准号:
16591864
负责人:
TOMOMURA Akito
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

TOMOMURA Akito的其他基金

相似基金

相关文献

中文摘要
翻译
钙调蛋白是从胰腺组织中分离、克隆的一种降钙因子,可能是急性胰腺炎的一种低钙因子。它属于弹性蛋白酶家族,但其降钙活性与蛋白酶活性之间没有明确的联系。我们发现钙调蛋白的降钙活性抑制了骨细胞的骨吸收和骨髓破骨细胞的形成。我们还发现,钙调蛋白抑制钙离子-钙调神经磷酸酶系统中的信号转导通路的RANKL诱导的破骨细胞形成。另一方面,钙调蛋白在脑内表达,其生理功能尚不清楚。我们研究钙调蛋白是否抑制阿尔茨海默病老年斑中淀粉样蛋白的形成。Caldecrin以时间依赖性方式消化淀粉样β肽40和42,并抑制淀粉样β肽42的淀粉样形成。此外,这些消化的肽片段的神经毒性消失。这些结果表明,在脑中表达的钙调蛋白通过蛋白酶活性促进淀粉样蛋白β并抑制淀粉样蛋白的形成。因此,本研究制备了钙调蛋白基因破坏小鼠,用于研究钙调蛋白在骨和神经系统中的生理和病理功能。将钙调蛋白基因的靶向载体重组到C57 BL/6胚胎干细胞中,并选择G418抗性克隆。通过主成分分析和Southern印迹杂交,我们获得了几个克隆。
英文摘要
Caldecrin is a serum calcium-decreasing factor which was purified and cloned from pancreas, and seems to be a hypocalcemic factor with acute pancreatitis. It belongs to the elastase family, but its calcium-decreasing activity did not clear connect with protease activity. We identified that the calcium-decreasing activity of caldecrin suppressed osteoclastic bone resorption and osteoclast formation from bone marrow. We also identified that caldecrin suppressed Ca ion-calcineurin system in the signal transduction pathway of the RANKL-induced osteoclstic formation. On the other hand, caldecrin expresses in the brain, and its physiological function is not clear. We examined whether caldecrin suppressed an amyloid formation in the senile plaque of Alzheimer's disease. Caldecrin digested amyloid β peptides 40 and 42 with time-dependent manner, and also suppressed amyloid formation of amyloid, β peptide 42. In addition, neurotoxicity of these digested peptide fragments was disappeared. These results suggest that caldecrin expressed in the brain digests amyloid β and suppresses amyloid formation by protease activity. Therefore we made caldecrin gene destruction mouse for the search of physiological and pathological functions in the bone and nervous system. A targeting vector for caldecrin gene was recombinated into an C57BL/6 embryonic stem cell and selected G418-resistant clones. We obtained several clones analyzed by PCA and southern blot hybridization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibitory mechanism of caldecrin on RANKL-stimulated signaling platform formation in the osteoclasts
  • 批准号:
    24592811
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.49万
  • 财政年份:
    2012
  • 负责人:
    TOMOMURA Akito
  • 依托单位:
Gene therapy with serum calcium-decreasing factor, caldecrin, for osteoporosis
  • 批准号:
    14571773
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    2002
  • 负责人:
    TOMOMURA Akito
  • 依托单位:
Exploration of genes and the functions affected by serum calcium-decreasing factor (caldecrin)
  • 批准号:
    11671852
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.05万
  • 财政年份:
    1999
  • 负责人:
    TOMOMURA Akito
  • 依托单位:
Analysis of Receptor for Bone Resorption Suppressor Caldecrin
  • 批准号:
    09671904
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    1997
  • 负责人:
    TOMOMURA Akito
  • 依托单位:
海外基金